Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inflammatory Lung Conditions Associated With COVID-19”

19 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 19 results

Not applicableStudy completedNCT04761913
What this trial is testing

Paediatric Inflammatory Multisystem Syndrome During COVID-19 Pandemic

Who this might be right for
Paediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-Cov-2
Anglia Ruskin University 40
Not applicableStudy completedNCT05972980
What this trial is testing

Ventilator-Associated Pneumonia in Critically Ill COVID-19 vs. Non-COVID-19 Patients

Who this might be right for
InfectionsCritical IllnessSuperinfection+3 more
University of Turin, Italy 200
Not applicableStudy completedNCT06784713
What this trial is testing

DIFFERENT SARS-COV-2 VARIANTS' EFFECT ON THE COURSE OF COVID-19 IN ESTONIAN CHILDREN

Who this might be right for
COVID - 19Diabetes MellitusPost-COVID Conditions+1 more
University of Tartu 127,277
Not applicableUnknownNCT04385004
What this trial is testing

Clinical, Biological and Histological Pulmonary and Renal Damage Associated With the SARS-CoV-2 Syndrome in Patients Admitted in ICU

Who this might be right for
Acute Respiratory Distress Syndrome
University Hospital, Strasbourg, France 320
Not applicableUnknownNCT05026892
What this trial is testing

Identification of Factors Associated With the Occurrence of Severe Forms of COVID-19 Infection in Patients With Inflammatory Rheumatism or Autoimmune Diseases

Who this might be right for
SARS-CoV2 InfectionRare DiseasesChronic Inflammatory Rheumatism+1 more
Assistance Publique - Hôpitaux de Paris 1,200
Not applicableStudy completedNCT05098600
What this trial is testing

The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic

Who this might be right for
Alopecia AreataAlopecia TotalisAlopecia Universalis+24 more
Faculty Hospital Kralovske Vinohrady 123
Early research (Phase 1)Study completedNCT04350736
What this trial is testing

First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19

Who this might be right for
Acute Lung Injury (ALI) Associated With COVID-19Inflammatory Lung Conditions Associated With COVID-19
Theravance Biopharma 54
Not applicableStudy completedNCT05394961
What this trial is testing

Factors Associated With Decisions to Withhold or Withdraw Intensive Care

Who this might be right for
SepsisARDS, HumanCOVID-19
Uppsala University 33,256
Testing effectiveness (Phase 2)Study completedNCT04374149
What this trial is testing

Therapeutic Plasma Exchange Alone or in Combination With Ruxolitinib in COVID-19 Associated CRS

Who this might be right for
Cytokine Release SyndromeCOVID19
Prisma Health-Upstate 20
Large-scale testing (Phase 3)Study completedNCT04475081
What this trial is testing

Use of a Live Attenuated Vaccine as an Immune-based Preventive Against COVID-19-associated Sepsis

Who this might be right for
Sepsis Syndrome
Louisiana State University Health Sciences Center in New Orleans 50
Large-scale testing (Phase 3)Ended earlyNCT04377620
What this trial is testing

Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT)

Who this might be right for
COVID-19
Incyte Corporation 211
Testing effectiveness (Phase 2)Looking for participantsNCT06052436
What this trial is testing

Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Control the Immune Hyperactivation Associated With COVID-19 and/or Acute Respiratory Distress Syndrome (THYTECH2)

Who this might be right for
Systemic Inflammatory Response Syndrome
Hospital General Universitario Gregorio Marañon 24
Large-scale testing (Phase 3)Active Not RecruitingNCT05619653
What this trial is testing

Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19

Who this might be right for
COVID-19 Associated Cardiac InvolvementRemodeling, Left VentricleRemodeling, Vascular+6 more
Valentina Puentmann 279
Not applicableNo Longer AvailableNCT04657458
What this trial is testing

Expanded Access for Use of bmMSC-Derived Extracellular Vesicles in Patients With COVID-19 Associated ARDS

Who this might be right for
Covid19ARDSHypoxia+1 more
Direct Biologics, LLC
Testing effectiveness (Phase 2)Study completedNCT04402866
What this trial is testing

TD-0903 for ALI Associated With COVID-19

Who this might be right for
Acute Lung Injury (ALI) Associated With COVID-19Lung Inflammation Associated With COVID-19
Theravance Biopharma 235
Not applicableLooking for participantsNCT04806620
What this trial is testing

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

Who this might be right for
Post-Acute COVID-19 SyndromeME/CFSRheumatic Arthritis+41 more
Brain Inflammation Collaborative 10,000
Large-scale testing (Phase 3)Study completedNCT04362137
What this trial is testing

Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm

Who this might be right for
Cytokine Storm (Covid-19)
Novartis Pharmaceuticals 432
Testing effectiveness (Phase 2)Looking for participantsNCT06684379
What this trial is testing

Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm for the Treatment of Acute Respiratory Distress Syndrome (ARDS) Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)

Who this might be right for
SARS-CoV-2Influenza, HumanRespiratory Syncytial Virus Infections+1 more
PEACHES BIOTECH 50
Not applicableStudy completedNCT04734678
What this trial is testing

Comparison of Tocilizumab Versus Tocilizumab/Infliximab in Patients With COVID-19-associated Cytokine Storm Syndrome

Who this might be right for
Covid19Cytokine StormCorona Virus Infection
Ain Shams University 153